Membership

Categories

View All
Autoimmune Diseases Brain Health Cardiovascular Health Metals Microbes Women’s Health

Conditions

View All
Alzheimer’s Dementia Anemia Autism spectrum disorder (ASD) Bacterial Vaginosis Breast Cancer Chronic Kidney Disease (CKD) Chronic Pelvic Pain (CPP) Crohn’s Disease Diabetes Type I End-Stage Renal Disease (ESRD) Endometriosis Erectile Dysfunction Female Infertility Graves’ Disease (GD) Hashimoto’s Thyroiditis

Definitions

View All
Aflatoxin Amsel’s Criteria Autoantibodies Blood-Brain Barrier (BBB) Bradford Hill Criteria Calprotectin Chelation Coelomic Metaplasia Theory Colibactin Drug Repurposing  EDTA Endometriomas Environmental Theory of Endometriosis Estrobolome Estrogen

Guides & Resources

View All
Endometriosis Guide Microbiome Diet for Endometriosis

Interventions

View All
Boric Acid Cholestyramine Clindamycin Clinoptilolite Zeolite Dimethylglyoxime (DMG) Hyperbaric Oxygen Therapy (HBOT) Lactoferrin Lactulose Low‑Nickel Diet (LNiD) Lugdunin Metformin Metronidazole Phage Therapy Photobiomodulation Probiotics

Supplements

View All
Essential Oils Flavones and Flavonols Guar Gum Pueraria Flower Extract (PFE)

Microbes

View All
Akkermansia muciniphila Clostridium perfringens E. coli Nissle 1917 Enterococcus faecalis Escherichia coli (E. coli) Fusobacterium nucleatum H pylori Listeria monocytogenes Microsporum canis (M. canis) Pseudomonas aeruginosa Staphylococcus aureus (S. Aureus) Streptococcus agalactiae (GBS) Streptococcus spp. Ureaplasma urealyticum (U. urealyticum)

Metals

View All
Arsenic (As) Cadmium (Cd) Copper (Cu) Gallium Iron (Fe) Lead (Pb) Magnesium (Mg) Manganese (Mn) Mercury Metalloestrogens Nickel Nickel in Escherichia coli: Metabolic and Pathogenic Roles Zinc

Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Fecal calprotectin biomarker in IBD: Clinical Use Increased intestinal absorption of foreign organic compounds in the presence of ethylenediaminetetraacetic acid (EDTA) Cytochrome c-549-an endogenous cofactor of cyclic photophosphorylation in the cyanobacterium Anacystis nidulans? Factors affecting the absorption and excretion of lead in the rat Akkermansia muciniphila in infectious disease: A new target for this next-generation probiotic? Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children Cadmium transport in blood serum Serum hepcidin concentrations in relation to iron status in children with type 1 diabetes The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse

Analysis of Salivary Microbiome in Patients with Alzheimer’s Disease

Our team reviews, analyzes, and summarizes the latest health and nutrition studies to help you be healthier. Updated daily.

Premium Content

We are an entirely self-funded, with no third-party ads or ties to food and supplement companies.

This study analyzed the salivary microbiome in Alzheimer’s disease, revealing reduced diversity and distinct microbial shifts, including Moraxella enrichment and APOE4-related differences, suggesting oral dysbiosis may contribute to neurodegeneration.

All articles (A-Z)

A B C D E F G I L M N O P R S T U V
A
Analysis of Salivary Microbiome in Patients with Alzheimer’s Disease
O
Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis
E
Effect of endometriosis on the fecal bacteriota composition of mice during the acute phase of lesion formation
S
Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study
D
Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine
V
Variation of Gut Mucosal Microbiome With Anti-Saccharomyces cerevisiae Antibody Status in Pediatric Crohn Disease
U
Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism
D
Dysbiosis of gut microbiota in a selected population of Parkinson’s patients
A
Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease
G
Gut microbiota in Parkinson’s disease: Temporal stability and relations to disease progression
T
The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients
The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function
A
Altered gut microbiota and microbial biomarkers associated with chronic kidney disease
D
Dysbiotic Subgingival Microbial Communities in Periodontally Healthy Patients With Rheumatoid Arthritis
G
Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders
C
Carious status and supragingival plaque microbiota in hemodialysis patients
S
Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health
G
Gut Microbiota Features in Young Children With Autism Spectrum Disorders
E
Endometriosis induces gut microbiota alterations in mice
G
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
V
Variations in oral microbiome profiles in rheumatoid arthritis and osteoarthritis with potential biomarkers for arthritis screening
I
Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis
A
Analysis of gut microbiota profiles and microbe-disease associations in children with autism spectrum disorders in China
B
Breast cancer in postmenopausal women is associated with an altered gut metagenome
A
Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease
F
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease
T
The nasal and gut microbiome in Parkinson’s disease and idiopathic rapid eye movement sleep behavior disorder
M
Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers
A
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
G
Gut microbiota in patients with Parkinson’s disease in southern China
A
A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
G
Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study
A
Alterations of the Gut Microbiota in Hashimoto’s Thyroiditis Patients
M
Molecular Alteration Analysis of Human Gut Microbial Composition in Graves’ disease Patients
A
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
G
Gut microbiome alterations in Alzheimer’s disease
P
Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome
N
New evidences on the altered gut microbiota in autism spectrum disorders
A
A comprehensive analysis of breast cancer microbiota and host gene expression
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
F
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients
G
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases
Gut microbiota in Parkinson disease in a northern German cohort
S
Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features
D
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome
M
More than constipation – bowel symptoms in Parkinson’s disease and their connection to gut microbiota
B
Breast tissue, oral and urinary microbiomes in breast cancer
M
Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients
Molecular detection of intrauterine microbial colonization in women with endometriosis
S
Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls
G
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
R
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn’s Disease
M
Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients
T
The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome
G
Gut microbiota in early pediatric multiple sclerosis: a case-control study
M
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
T
The microbiome of the oral mucosa in irritable bowel syndrome
A
Alterations of the human gut microbiome in multiple sclerosis
I
Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children
Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study
A
An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis
C
Colonic bacterial composition in Parkinson’s disease
D
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
F
Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis
A
Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes
G
Gut microbiota are related to Parkinson’s disease and clinical phenotype
T
The treatment-naive microbiome in new-onset Crohn’s disease
M
Microbial dysbiosis is associated with human breast cancer
F
Fecal microbiota imbalance in Mexican children with type 1 diabetes
O
Oral status in patients with early rheumatoid arthritis: a prospective, case-control study
G
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study
R
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children
F
Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome
A
Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
I
Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome
IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation
P
Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis
M
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome
G
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome
A
Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome
P
Pyrosequencing study of fecal microflora of autistic and control children
L
Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients
Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Yes, I want to help shape the future of microbiome medicine.